Transcat FY2029 EPS Estimate Lifted by Northland Securities

Transcat, Inc. (NASDAQ:TRNS) – Research analysts at Northland Securities raised their FY2029 earnings per share estimates for Transcat in a research report issued on Tuesday, January 20th. Northland Securities analyst E. Jackson now anticipates that the scientific and technical instruments company will post earnings of $2.96 per share for the year, up from their previous estimate of $2.95. Northland Securities currently has a “Strong-Buy” rating on the stock. The consensus estimate for Transcat’s current full-year earnings is $2.30 per share. Northland Securities also issued estimates for Transcat’s FY2030 earnings at $3.51 EPS.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings results on Monday, November 3rd. The scientific and technical instruments company reported $0.44 EPS for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.02). The firm had revenue of $82.27 million for the quarter, compared to the consensus estimate of $79.51 million. Transcat had a net margin of 3.75% and a return on equity of 6.81%.

Other equities research analysts also recently issued reports about the stock. Zacks Research raised shares of Transcat from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 7th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Transcat in a research note on Monday, December 29th. Two equities research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $105.33.

Transcat Stock Down 0.4%

TRNS stock opened at $63.90 on Thursday. The stock’s 50 day simple moving average is $58.09 and its 200 day simple moving average is $70.01. Transcat has a fifty-two week low of $50.23 and a fifty-two week high of $103.74. The company has a debt-to-equity ratio of 0.38, a quick ratio of 2.06 and a current ratio of 2.43. The company has a market cap of $596.19 million, a P/E ratio of 52.38 and a beta of 0.78.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Transcat by 6.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,462 shares of the scientific and technical instruments company’s stock valued at $407,000 after buying an additional 325 shares during the period. Jane Street Group LLC bought a new stake in shares of Transcat in the 1st quarter valued at about $1,674,000. Riverbridge Partners LLC boosted its holdings in Transcat by 94.3% during the 2nd quarter. Riverbridge Partners LLC now owns 440,747 shares of the scientific and technical instruments company’s stock valued at $37,887,000 after acquiring an additional 213,927 shares during the period. Truist Financial Corp bought a new position in Transcat during the 2nd quarter worth approximately $318,000. Finally, Hardy Reed LLC purchased a new position in Transcat in the 2nd quarter worth approximately $217,000. 98.34% of the stock is currently owned by hedge funds and other institutional investors.

About Transcat

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.